Progress in the pursuit of therapeutic adenosine receptor antagonists.
about
Microwave-assisted ring closure reactions: synthesis of 8-substituted xanthine derivatives and related pyrimido- and diazepinopurinedionesAdenosine receptors as therapeutic targetsStructure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksRecent developments in adenosine receptor ligands and their potential as novel drugsTransporter protein and drug-conjugated gold nanoparticles capable of bypassing the blood-brain barrierSolid-phase synthesis of 7-substituted 3H-imidazo[2,1-i]purines.Structure-based discovery of A2A adenosine receptor ligands.Xanthines as adenosine receptor antagonists.Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition processPyrazolo derivatives as potent adenosine receptor antagonists: an overview on the structure-activity relationshipsMedicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.Introduction to adenosine receptors as therapeutic targets.Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility.Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors.Internalization and desensitization of adenosine receptors.Predicting Subtype Selectivity for Adenosine Receptor Ligands with Three-Dimensional Biologically Relevant Spectrum (BRS-3D).The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches.Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands.Reciprocal modulation of anti-IgE induced histamine release from human mast cells by A₁ and A(2B) adenosine receptors.Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease.Expression of calcitonin gene-related peptide, adenosine A2a receptor and adenosine A1 receptor in experiment rat migraine models.Latest QSAR study of adenosine A[Formula: see text] receptor affinity of xanthines and deazaxanthines.Design and evaluation of xanthine based adenosine receptor antagonists: potential hypoxia targeted immunotherapies.Adenosine and its receptors as therapeutic targets: An overview.P2Y receptor regulation of sodium transport in human mammary epithelial cells.Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes.Reconstruction of the adenosine system by bone marrow-derived mesenchymal stem cell transplantation.Adenosine A3 receptor and cardioprotection: enticing, enigmatic, elusive.Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.Fluorinated Adenosine A2A Receptor Antagonists Inspired by Preladenant as Potential Cancer Immunotherapeutics.2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists.Synthesis and properties of a new water-soluble prodrug of the adenosine A 2A receptor antagonist MSX-2.Unfolding Role of a Danger Molecule Adenosine Signaling in Modulation of Microbial Infection and Host Cell Response.Organoruthenium antagonists of human A₃ adenosine receptors.Discovery of benzothiazolylquinoline conjugates as novel human A3 receptor antagonists: biological evaluations and molecular docking studies.New frontiers for the treatment of noncardiac chest pain: the adenosine receptors.Navigating in chromone chemical space: discovery of novel and distinct A3 adenosine receptor ligands
P2860
Q21198735-4AA0C750-AB3D-49C4-993B-984E77AF2C28Q24632095-9F4166E8-F70B-48B1-AD6B-F010F8669E51Q26740559-ADFB3F90-BEB2-449A-862B-8493C5BB17C6Q27687253-35F297F4-E871-4A28-ADE0-70FC9C545AF1Q28834214-EA8F8AF6-4344-4DED-B9D3-A72D5E16028BQ33271336-BC8A4C5A-6E8E-4B09-9EEA-4875C9D8E723Q33560239-4090CAC7-71D1-49FE-8BC7-68EB0CD4DEC0Q34139398-3077B05F-ED8F-4AB5-813D-FCCAD7457800Q34313641-D2BB08E7-D98C-49CE-B79C-FF9ED56F5511Q34365007-480D7806-78A0-40A5-905B-951153E54842Q34676680-49C45576-45D2-4932-9F43-863C73CF5878Q35020369-EF603CDF-87CB-403A-8F9A-21DFB8A49774Q35545074-0555A55A-1C04-4871-9DBA-079B16F5BAE4Q36146803-E7C36C0F-4BDA-4C6E-9DEE-DE6ED05D951AQ36153376-D3065236-7BC0-40A2-89B9-ADE4E748F619Q36626953-6475DCCC-377C-4C8C-9517-FF0861846411Q36635966-808AE0A6-158F-464B-8345-AE040237942DQ37119883-47E9286C-382E-4935-96D1-A8996D0CD28BQ37393936-1FAEA9AB-C758-49AE-BF95-85CB290A77B4Q37957791-A09B732C-7353-4F19-BA71-2EF933E37F7BQ37995704-4B0563D0-DA26-4CAB-835B-E88B8D2C8BADQ38650036-B136EB47-76A1-4276-9C05-5262CB070823Q38691918-7A4CF3AE-1D72-4E3E-9E0D-0C40F5F0D700Q38717999-140422CC-8281-41AE-943E-6D5BC7C397F9Q38986357-E1298CAC-FABC-46A4-A5B6-F7095DB724FDQ39078481-A5274477-39D6-4CC4-84C2-3F20658679F4Q42059361-1631794A-6C22-47AF-A161-CB34E4A165C4Q42517866-84FF74CD-B462-4E2E-A337-C3C07FC7D483Q43049495-1869C95C-748D-42D2-84AF-A07FC950B7BBQ43157485-76017C69-312E-4D7A-BDE2-33726B993652Q43214412-45DE3732-D5E9-4F2E-ACD6-E42847D9ABF4Q43944774-6ED096B0-E594-4FBC-B0D9-F9AB55F5C94AQ45305819-D4FFA6B8-A45D-42D1-A861-39EF29DD1373Q46475985-DF10382A-EED7-4284-A00D-F13B5C01BD18Q46729445-BD02E266-0A10-4F0A-9338-66FAD8ABF86AQ48284423-1A9E7D62-321C-4720-BE1E-A17894E00502Q51047023-E11410FC-AA12-4B72-9707-00ADCB0DA07BQ52668077-FC3A6999-DFE7-4CF8-854B-EB67CBC5245BQ53236670-750D9A6F-B2AE-45C9-8B77-9AEBE359331AQ56990903-D840B8E5-829C-4CD0-BD40-2ED22275C7C5
P2860
Progress in the pursuit of therapeutic adenosine receptor antagonists.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@ast
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@en
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@nl
type
label
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@ast
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@en
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@nl
prefLabel
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@ast
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@en
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@nl
P2860
P50
P356
P1476
Progress in the pursuit of therapeutic adenosine receptor antagonists.
@en
P2093
Giampiero Spalluto
P2860
P304
P356
10.1002/MED.20048
P577
2006-03-01T00:00:00Z